Zenth Bio advances the frontiers of synthetic biology, gene editing, computational therapeutics, and sustainable biomanufacturing. From lab to legacy.
Integrated platforms spanning discovery, development, and deployment of next-generation biological solutions.
CRISPR-Cas systems, base editing, and viral/non-viral delivery vectors for targeted genetic treatments and hereditary disease intervention.
Design-build-test cycles for engineered microorganisms, metabolic pathway optimization, and cellular computing architectures.
AI-driven protein folding, multi-omics integration, digital twin modeling of biological systems, and predictive pharmacology.
Continuous bioprocessing, single-use systems, chromatography automation, and GMP-compliant scale-up for biologics and mRNA products.
Liquid biopsy platforms, NGS panels, CRISPR-based detection, and AI-assisted pathology for early intervention and monitoring.
Nitrogen-fixing microbiomes, drought-resilient crop traits, biodegradable polymers, and carbon-sequestering algae systems.
Track our therapeutic and platform advancements through preclinical, clinical, and commercialization phases.
Strategic facilities enabling 24/7 research continuity and cross-continental collaboration.
Partner with our research divisions, invest in pipeline assets, or explore talent opportunities in biological engineering.